Given the extreme rarity of ALDHhigh/CD44+/CD24+ cells in direct xenograft tumors (0.015% of all tumor cells), purification of ALDHhigh/CD44+/CD24+ cells was not technically feasible due to extended cell-sorting times and the mass quantity of tumor required to obtain even a small number of such cells. This evidence concerns the gene CD44 and neoplasm.